hsa-miR-1268a
Submitted by Anonymous on Wed, 10/30/2019 - 22:16
Pubmed
Gene symble | Title | PMID | Curated descirption | Category | Literature category |
---|---|---|---|---|---|
hsa-miR-1268a | Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma | 26152337 | Polymorphisms in pre-miRNAs, such as rs28599926 in?miR-1268a, can be used as biomarkers for AFB1-related HCC | biomarker | BC/OC research |
hsa-miR-1268a | Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma | 27796321 | MicroRNA-1268a may be an independent prognostic factor for HCC patients, and that decreasing microRNA-1268a expression may be beneficial for post-operative adjuvant TACE treatment in HCC | biomarker | BC/OC research |
hsa-miR-1268a | miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma | 29876787 | MiR-1268a and elucidated its role in modulating TMZ-resistance of GBM cells by targeting ABCC1 | mechanism | BC/OC research |
hsa-miR-1268a | Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer | 30608951 | MiR-1268a was specifically enriched in SW480-Exos and miR-107 was enriched in only SW480-CL released EVs | mechanism | BC/OC research |
hsa-miR-1268a | The microRNA-1268a rs28599926 polymorphism modified diffusely infiltrating astrocytoma risk and prognosis | Link | MiR-1268a rs28599926 polymorphism may be associated with DIA risk and prognosis | biomarker | BC/OC research |
Survival analysis
Pathways
Enriched Terms | Cross Refer. |
---|---|
Biosynthesis of unsaturated fatty acids | KEGG |
Lysine degradation | KEGG |
Fatty acid metabolism | KEGG |
Glycolysis / Gluconeogenesis | KEGG |
Transcriptional misregulation in cancer | KEGG |
Chronic myeloid leukemia | KEGG |
Acute myeloid leukemia | KEGG |
Pathways in cancer | KEGG |
Bacterial invasion of epithelial cells | KEGG |
Oxidative phosphorylation | KEGG |